Mackie Research Capital analyst Andre Uddin upgraded Theratechnologies (THTX) to Buy from Speculative Buy.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THTX:
- Theratechnologies Resumes EGRIFTA SV® Distribution Following FDA Clearance
- Theratechnologies to resume distribution of EGRIFTA
- Theratechnologies expects Egrifta SV shortage this month
- Impending Shortage of Theratechnologies’ EGRIFTA SV® Amid Manufacturing Shutdown
- Theratechnologies Seeks FDA Approval for Manufacturing Changes to EGRIFTA SV®